Advertisement

 
 
 
 
 
 
 
 
 
 
Average: 4 (1 vote)

Vol. 13 - Num. 52

Evidence based Pediatrics

Is it necessary to perform an electrocardiogram in all children with attention deficit disorder before starting treatment with psychostimulants?

María Aparicio Rodrigoa, Javier González de Diosb, J Ramos Lizanac

aPediatra. CS Entrevías. Facultad de Medicina. Universidad Complutense de Madrid. Madrid. España.
bServicio de Pediatría. Hospital General Universitario de Alicante. Departamento de Pediatría. Universidad Miguel Hernández. ISABIAL-Instituto de Investigación Sanitaria y Biomédica de Alicante. Alicante. España.
cServicio de Pediatría. Hospital de Torrecárdenas. Almería. España.

Correspondence: M Aparicio. E-mail: maria.aparicio.rodrigo@gmail.com

Reference of this article: Aparicio Rodrigo M, González de Dios J, Ramos Lizana J. Is it necessary to perform an electrocardiogram in all children with attention deficit disorder before starting treatment with psychostimulants? Rev Pediatr Aten Primaria. 2011;13:629-40.

Published in Internet: 13-12-2011 - Visits: 15061

Abstract

The authors didn’t find differences on the rate of cardiovascular events or death between children exposed and unexposed to stimulant medication. They don’t find appropriate to perform an electrocardiogram (EKG) or referral to cardiology of all children with attention deficit and hyperactivity disorder (ADHD) before starting stimulant medication. Cardiology referral should be considered only if cardiac risk factors are detected.

Reviewer’s commentary: at present there isn’t enough evidence to justify the performance of an EKG as screening previous to initiate medical stimulant medication in children with ADHD. It seems reasonable to perform a careful history and physical examination (blood pressure and cardiac frequency included) and referral to cardiology only when cardiac risk factors or cardiac diseases are detected.

Keywords

Atomoxetin Attention-deficit hyperactivity disorder Cardiovascular disease Central nervous system stimulants Methylphenidate Sudden death

 

Comments

This article has no comments yet.